This invention pertains to a method for chemically synthesising novel classes of silver complexes that target specific forms of cancer with demonstrable anticancer activity in cell culture (in vitro). Most noteworthy is thus far, these complexes have better preliminary results than standard cisplatin. The chemistry is novel, and the discovery of convincing and selective anticancer activity thereof serendipitous.

Intellectual Property Protection

Opportunity type

Technology Readiness Level